- Nasopharyngeal Cancer
News & Events
On this page
NCATS Co-Sponsored Conferences
Workshop on Harmonization of EBV Testing for Nasopharyngeal Cancer, Monday, November 16, 2015 - Thursday, November 17, 2016
Location: Bethesda, MD
Description: The National Cancer Institute (NCI) is convening a workshop on the harmonization of EBV testing that might have clinical utility in treatment decision-making for advanced nasopharyngeal cancer. The purpose of the workshop is to bring together experts in assay development, clinical laboratory directors, and head and neck oncologists to assess the need for harmonization of EBV testing, identify best approaches to establish harmonization, and explore ways to effect widespread adoption of harmonized assay procedures and references.
Advancing Symptom Clusters Research on Rare Cancers, Wednesday, June 17, 2015
Location: NIH Neuroscience Building, Bethesda, MD
Description: <p>It is intended that the in-depth, interdisciplinary dialogue of this expert working group will formulate an emerging consensus on a working definition of symptom clusters and, specific gaps and opportunities that provide a foundation for a transformative strategic blueprint to guide future symptom cluster research in rare cancers. In addition, it is anticipated that workshop proceedings will inform a funding opportunity announcement.</p>
Rare Tumors Initiative Symposium Strategies to Develop Therapies for Rare Tumors: Small Numbers, but Big Opportunities , Wednesday, June 17, 2015
Location: NIH Natcher Conference Center, Bethesda, MD
Description: The goals of this symposium are to increase communication and build networks between researchers working in rare tumors across NIH, and to get input from patient groups, industry, and the FDA on how to overcome the biggest hurdles in the development of therapies for rare tumors. The Rare Tumors Initiative at NCI, CCR will use this information to prioritize goals for the future and will prepare a white paper summary to help guide researchers worldwide.
Overcoming Barriers to International Clinical Trials for Rare Cancers , Friday, December 10, 2010
Location: Bethesda, Maryland
Description: The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.